Centrosome numbers are tightly regulated during the cell cycle. A new study shows that the PIDDosome prevents the propagation of cells carrying amplified centrosomes via p53 stabilisation and p21-mediated cell-cycle arrest, thus ensuring the maintenance of normal centrosome numbers.
The centrosome -the main microtubuleorganising centre in animal cells -is duplicated once per cell cycle, much like DNA [1] . This tightly regulated duplication cycle ensures that, at the end of cell division, each daughter cell inherits one centrosome. While the mechanisms controlling centrosome numbers during the cell cycle are still unclear, it is well established that the correct number of centrosomes is vital to ensure genomic stability. Both amplification and loss of centrosomes have been reported to contribute to chromosome instability by promoting chromosome mis-segregation during mitosis [2] [3] [4] [5] . Thus, because chromosome instability is detrimental for individual cells and can also facilitate tumour formation [6] , it is not surprising that mechanisms exist to prevent the proliferation of cells with an abnormal number of centrosomes. In a recent study, Villunger and colleagues [7] describe a new mechanism by which activation of the PIDDosome and consequent p53 stabilisation limit the propagation of cells with extra centrosomes.
Proliferation of cells that have lost centrosomes or amplified centrosomes is inhibited by the activation of the p53 pathway [5, 8] . Recent work has shed some light on the mechanism leading to p53-dependent cell-cycle arrest upon loss of centrosomes. Centrosome loss, as well as prolonged mitosis, leads to stabilisation of p53 via p53-binding protein 1 (53BP1) and the deubiquitinase USP28, independently of DNA damage [9] [10] [11] . Importantly, loss of 53BP1 and USP28 does not prevent cell-cycle arrest induced by extra centrosomes [9] [10] [11] , suggesting that different signalling pathways are involved in p53 activation in response to different types of centrosomal abnormalities. In agreement with this, previous work has suggested that the presence of extra centrosomes leads to p53 stabilisation via activation of the Hippo pathway kinase LATS2 [12] . What exactly triggers these signalling responses that culminate in the activation of the p53 pathway remains elusive. However, because the cell-cycle arrest in response to centrosome loss or amplification is mediated by different pathways, it seems unlikely that cells have mechanisms that directly 'count' centrosome number; instead, activation of different stress responses following loss or amplification of centrosomes could indirectly trigger p53 activation.
Several stress responses trigger activation of the endopeptidase caspase-2 to limit the proliferation of 'damaged' cells [13] . Caspase-2 associates with p53-induced protein with a death domain 1 (PIDD1) and the adaptor protein RAIDD to form the PIDDosome, which has been shown to play a role in apoptosis in response to DNA damage [14] . However, in vivo work suggests that a DNA-damage response exists in the absence of a functional PIDDosome, raising questions regarding the specific triggers that lead to PIDDosome activation [15] . In the new study, Fava et al. [7] set out to identify activators of the PIDDosome and found that conditions that cause cytokinesis failure (which leads to the generation of tetraploid cells) but not mitotic arrest alone induced caspase-2 activation, as measured by cleavage of the E3 ubiquitin ligase MDM2, a p53 inhibitor. MDM2 cleavage leads to p53 stabilisation and p21-induced cellcycle arrest in both cancer and nontransformed cell lines in which cytokinesis has failed. CRISPR-Cas9-mediated depletion of the PIDDosome components (caspase-2, RAIDD and PIDD1) prevents MDM2 cleavage and p53 stabilisation in tetraploid cells, suggesting that the PIDDosome functions as a single unit to restrict the proliferation of tetraploid cells [7] . Surprisingly, these authors demonstrate that PIDDosome-mediated p53 stabilisation occurs selectively in response to cytokinesis failure, since PIDDosome-deficient cells can still accumulate p53 and undergo cell-cycle arrest in response to DNA damage and mitotic arrest. Indeed, DNA damage and mitotic arrest do not seem to cause MDM2 cleavage, supporting the specificity of caspase-2-mediated MDM2 cleavage in response to tetraploidy [7] . The authors also found that, while depletion of LATS2 can partly override the cell-cycle arrest caused by cytokinesis failure, it does not prevent caspase-2 activation and p53 stabilisation, suggesting that a distinct mechanism controls p53 activation upon cytokinesis failure [7] . Fava et al. showed that stabilisation of p53 could also be observed in vivo in mouse hepatocytes that become tetraploid after weaning and that this p53 accumulation could be prevented upon knockdown of caspase-2. The authors demonstrate that p53 stabilisation in hepatocytes is likely controlled by the PIDDosome since no further increase in hepatocyte ploidy was observed in mice lacking both p53 and caspase-2 [7] .
Cytokinesis failure leads to tetraploid cells that contain twice the normal ploidy and double the normal centrosome number [1] . To distinguish between whether higher DNA or higher centrosome content was activating the PIDDosome, the authors used centrinone [5] , an inhibitor of the centriole assembly regulator Polo-like kinase 4 (PLK4), to reduce the number of centrosomes in tetraploid cells and found that this prevents PIDDosome activation and p53 stabilisation [7] . In addition, overexpression of PLK4, known to induce centrosome amplification without changes in ploidy [16] , was sufficient to trigger PIDDosome activation and p53 accumulation, indicating that centrosome amplification, and not increased ploidy, activates caspase-2 and causes p53-mediated cell-cycle arrest (Figure 1 ) [7] . Strikingly, caspase-2 activation and p53 stabilisation were only observed 48 hours after the induction of centrosome amplification by PLK4 overexpression, a time that coincides with the appearance of extra mother centrioles; mother centrioles, which become decorated with distal appendages, are a sign of fully mature centrioles [1] . Normal cells have one mother centriole per cell cycle; however, after 48 hours of PLK4 overexpression, detection of markers for distal appendages, such as Cep164, reveals the presence of multiple mother centrioles, suggesting that excessive mother centrioles could trigger PIDDosome activation [7] . In support of this idea, the authors also found that PIDD1 localises to the mother centriole in control cells and upon PLK4 overexpression. Depletion of Odf2/ cenexin, which is required for the formation of the distal and subdistal appendages, led to loss of the distal appendages from mother centrioles, loss of PIDD1 centriolar localisation, and abrogation of both caspase-2 activation and p53-mediated cell-cycle arrest upon cytokinesis failure [7] . The authors propose that extra mother centrioles trigger local PIDDosome activation by promoting centrosomal PIDD1 localisation.
While the results presented here provide a compelling explanation of how PIDDosome activation and p53 stabilisation can prevent the proliferation of cells with supernumerary centrosomes, it remains unclear how the PIDDosome is activated in these cells. The authors propose that PIDD1 (and the PIDDsome) could be part of a mechanism that directly monitors centrosome number [7] . While this is an attractive idea, it still remains to be tested. Is PIDD1 localisation to the mother centriole required for PIDDosome activation? The authors showed that conditions that prevented centriole maturation and PIDD1 localisation abrogated cell-cycle arrest. However, the lack of mature centrioles could alter centrosomal signalling or microtubule attachment, which in turn could indirectly cause PIDDsome activation. It would be important to assess whether loss of PIDD1 centrosomal localisation in cells with extra mother centrioles would prevent PIDDosome activation and cell-cycle arrest.
In the context of tumours, the work from Fava et al. [7] suggests that loss of caspase-2 could facilitate tumour Increased numbers of centrosomes lead to caspase-2 activation via the PIDDosome. Caspase-2 is an endopeptidase, which, when activated, cleaves the p53 inhibitor MDM2, promoting p53 stabilisation. Stabilised p53 can translocate to the nucleus where it activates the transcription of several genes, including the cell-cycle inhibitor p21, thus causing cell-cycle arrest.
R238 Current Biology 27, R218-R241, March 20, 2017 Current Biology Dispatches progression by allowing the proliferation of cells with extra centrosomes [17, 18] . Remarkably, recent work showed that mutations in the BCL9L gene impair caspase-2 expression and MDM2 cleavage and promote tolerance to chromosome instability in human colorectal tumours [19] . Thus, it is possible that loss of caspase-2 is part of an adaptation mechanism that allows cancer cells to proliferate despite the presence of extra centrosomes, thereby promoting chromosome instability [3, 12] .
It is important to note that loss of caspase-2 alone might not be sufficient to propagate cells with extra centrosomes.
As the authors observed, efficient proliferation of tetraploid cells with extra centrosomes was prevented in caspase-2-deficient cells due to defects in centrosome clustering mechanisms that are essential for the survival of cells with extra centrosomes [7, 20] . As strategies to therapeutically target cancer cells with amplified centrosomes are under development, it would be extremely valuable to know whether loss of caspase-2 or the PIDDosome could be used as biomarkers of centrosome amplification.
